Early treatment response in alcohol dependence with extended-release naltrexone. OBJECTIVE: We sought to determine the time course for onset of effect of intramuscular injectable extended-release naltrexone (XR-NTX), which has demonstrated efficacy for alcohol dependence. METHOD: A post hoc analysis of a randomized, double-blind, placebo-controlled, multicenter study was conducted. In the study, actively drinking men and …∞
Posted in Adjunctive therapy, Alcohol, Alcoholism, Pharmacotherapy, Research and tagged alcohol dependence, counseling, drinking, Naltrexone, psychosocial, treatment. Use this permalink for a bookmark.
United States Food and Drug Administration (FDA) approved acamprosate for use in conjunction with psychosocial support in the maintenance of abstinence in alcohol-dependent patients
Posted in Adjunctive therapy, Alcohol, Alcoholism, Medication, Pharmacotherapy, Relapse prevention, Research, Training and tagged abstinence, acamprosate, alcohol dependent, DSM-III, FDA, patients, psychosocial. Use this permalink for a bookmark.